Recent Performance of Medicinova Inc (MNOV) Stock: A Closer Look

Kevin Freeman

Medicinova Inc [MNOV] stock is trading at $1.6, up 1.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MNOV shares have gain 5.26% over the last week, with a monthly amount glided 8.11%, and seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Medicinova Inc [NASDAQ: MNOV] stock has seen the most recent analyst activity on March 10, 2021, when Maxim Group initiated its Buy rating and assigned the stock a price target of $15. On March 28, 2018, B. Riley FBR Inc. initiated with a Buy rating and assigned a price target of $22 on the stock. Credit Suisse started tracking the stock assigning a Outperform rating. Ladenburg Thalmann reiterated its recommendation of a Buy and reduced its price target to $6 on January 04, 2013. MLV & Co downgraded its rating to Hold for this stock on May 24, 2012. In a note dated October 18, 2011, MLV Capital reiterated an Buy rating on this stock and revised its target price from $13 to $6.

Medicinova Inc [MNOV] stock has fluctuated between $1.13 and $2.06 over the past year. Medicinova Inc [NASDAQ: MNOV] shares were valued at $1.6 at the most recent close of the market.

Analyzing the MNOV fundamentals

Gross Profit Margin for this corporation currently stands at -0.1% with Operating Profit Margin at -51.85%, Pretax Profit Margin comes in at -46.54%, and Net Profit Margin reading is -46.57%. To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.25 and Total Capital is -0.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.01.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.

Ratios To Look Out For

For context, Medicinova Inc’s Current Ratio is 9.86. Further, the Quick Ratio stands at 9.86, while the Cash Ratio is 9.76. Considering the valuation of this stock, the price to sales ratio is 302.42, the price to book ratio is 1.78.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.